Feng Yan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Decision Making

Tyrosine Kinase

Cancer Stem Cells

Small Cell Lung Cancer

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Cancer biology & therapy

Journal of translational medicine

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Dongping Mo, Xun Tang, Yuyan Ma, Dayu Chen, Weiguo Xu, Ning Jiang, Junyu Zheng, Feng Yan
tRNA-derived fragment 3'tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer. Journal of translational medicine 22 (1) (2024)
Xiaoming Wang, Dayu Chen, Yuyan Ma, Dongping Mo, Feng Yan
Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Fei Yan, Yue Teng, Xiaoyou Li, Yuejiao Zhong, Chunyi Li, Feng Yan, Xia He
Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer biology & therapy 25 (1) (2024)
Xiaoming Wang, Dayu Chen, Yuyan Ma, Dongping Mo, Feng Yan
Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Xiaoming Wang, Dayu Chen, Yuyan Ma, Dongping Mo, Feng Yan
Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Fei Yan, Yue Teng, Xiaoyou Li, Yuejiao Zhong, Chunyi Li, Feng Yan, Xia He
Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer biology & therapy 25 (1) (2024)
Fei Yan, Yue Teng, Xiaoyou Li, Yuejiao Zhong, Chunyi Li, Feng Yan, Xia He
Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer biology & therapy 25 (1) (2024)
Fei Yan, Yue Teng, Xiaoyou Li, Yuejiao Zhong, Chunyi Li, Feng Yan, Xia He
Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer biology & therapy 25 (1) (2024)
Dongping Mo, Xun Tang, Yuyan Ma, Dayu Chen, Weiguo Xu, Ning Jiang, Junyu Zheng, Feng Yan
tRNA-derived fragment 3'tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer. Journal of translational medicine 22 (1) (2024)
Xiaoming Wang, Dayu Chen, Yuyan Ma, Dongping Mo, Feng Yan
Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Dongping Mo, Xun Tang, Yuyan Ma, Dayu Chen, Weiguo Xu, Ning Jiang, Junyu Zheng, Feng Yan
tRNA-derived fragment 3'tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer. Journal of translational medicine 22 (1) (2024)
Fei Yan, Yue Teng, Xiaoyou Li, Yuejiao Zhong, Chunyi Li, Feng Yan, Xia He
Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer biology & therapy 25 (1) (2024)
Xiaoming Wang, Dayu Chen, Yuyan Ma, Dongping Mo, Feng Yan
Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Fei Yan, Yue Teng, Xiaoyou Li, Yuejiao Zhong, Chunyi Li, Feng Yan, Xia He
Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer biology & therapy 25 (1) (2024)
Xiaoming Wang, Dayu Chen, Yuyan Ma, Dongping Mo, Feng Yan
Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Li Tang, Da Wei, Xinyu Xu, Dongping Mo, Daofu Cheng, Feng Yan
FOXO1-regulated lncRNA CYP1B1-AS1 suppresses breast cancer cell proliferation by inhibiting neddylation. Breast cancer research and treatment (2023)
Linping Yan, Huanhuan Chen, Li Tang, Pan Jiang, Feng Yan
Super-enhancer-associated long noncoding RNA AC005592.2 promotes tumor progression by regulating OLFM4 in colorectal cancer. BMC cancer 21 (1) (2021)
Li Tang, Da Wei, Xinyu Xu, Xuelian Mao, Dongping Mo, Linping Yan, Weiguo Xu, Feng Yan
Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1. NPJ breast cancer 7 (1) (2021)
Huanhuan Chen, Junyu Zheng, Linping Yan, Xin Zhou, Pan Jiang, Feng Yan
Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer. Journal of clinical laboratory analysis 35 (6) (2021)